3.630SEK-0.82%Mkt Cap: 64.16M $P/E: —1d ago
Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, Europe, Asia, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposit…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Pricier
1M Perf
Higher
Indicators:|
Key Statistics
Company
Market Cap64.16M $
Enterprise Value57.27M $
Revenue (TTM)5.20M $
Gross Profit5.35M $
Net Income (TTM)-1.09M $
Revenue/Share0.0321 USD
Last Price3.630 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees16
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)16.50
PEG—
EV/EBITDA-81.78
EV/Revenue11.00
P/S12.33
P/B5.28
EPS (TTM)-0.09
EPS (Forward)0.22
52W Range
1.40062% of range5.000
52W High5.000 SEK
52W Low1.400 SEK
Profitability
Gross Margin154.74%
Oper. Margin-222.20%
EBITDA Margin-13.46%
Profit Margin-31.50%
ROE-11.22%
ROA-8.24%
Growth
Revenue Growth-20.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-139.84K $
CapEx (TTM)2.37M $
FCF Margin2.87%
FCF Yield0.23%
Net Debt-6.89M $
Net Debt/EBITDA9.84
Balance Sheet
Debt/Equity0.02
Current Ratio2.06
Quick Ratio2.06
Book Value/Sh0.6880 SEK
Cash/Share0.3950 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.184.79M
Float140.01M
Insiders37.59%
Institutions2.40%
Technical
SMA 503.866 (-6.1%)
SMA 2003.252 (+11.6%)
Beta1.79
S&P 52W Chg20.05%
Avg Vol (30d)470.66K
Avg Vol (10d)478.48K
Technical Indicators
RSI (14)37.5
MACD-0.0825
MACD Signal0.0180
MACD Hist.-0.1005
BB Upper4.863 SEK
BB Middle4.157 SEK
BB Lower3.450 SEK
BB Width34.02%
ATR (14)0.2568 SEK
Vol Ratio (20d)0.35x